Patient characteristics
| Controls | Crohn’s disease | Ulcerative colitis | |
|---|---|---|---|
| *Values are mean (SD) [range]. | |||
| †Crohn’s disease activity index (CDAI).25 | |||
| ‡Activity assessed according to Rachmilewitz.26 | |||
| ¶Some patients had combined therapy. | |||
| n | 75 | 111 | 69 |
| Age (y)* | 36.8 (14.5) [18.2–78.8] | 33.4 (13.6) [19.1–75.8] | 36.4 (12.4) [18.8–64.7] |
| Sex (M/F) | 33/42 | 50/61 | 36/33 |
| Disease duration (y)* | 3.12 (4.93) [0–23.3] | 4.69 (6.8) [0–23.8] | |
| Activity score (mean (SD))* | 257 (67)† | 7.7 (2.1)‡ | |
| Medication¶ | |||
| None | 75 | 25 | 10 |
| Aminosalicylate | 46 | 36 | |
| Systemic steroid | 30 | 21 | |
| Topical steroid | 4 | 2 | |
| Azathioprine | 12 | 2 | |
| Antibiotic | 11 | – | |
| Ciclosporine | 1 | 1 | |